Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12015-020-09999-0 http://scihub22266oqcxt.onion/10.1007/s12015-020-09999-0 32592163!7317273!32592163     free     free     free Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Stem+Cell+Rev+Rep 2021 ; 17 (1): 153-162 Nephropedia Template TP {{tp|p=32592163|t=2021. Primed Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients |pdf=|usr=}}{{32592163}} gab.com Text Primed Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients JO: Stem Cell Rev Rep http://www.kidney.de/pget.php?&tw=1&pmid=32592163 #FOAvip The COVID19 pandemic, designated as a public health crisis by the World Health Organization (WHO), is rapidly spreading around the world impacting the health and economy of almost all the countries. The data of hospitalized COVID19 patients, especially those with serious illness, indicate the involvement of immunopathological complications. As no effective treatment is currently available, we propose 'Primed' Mesenchymal Stem Cells (MSCs) as a therapeutic alternative to tackle devastating epidemic. The individual response to MSCs treatment is heterogeneous. During the treatment of infectious pathology, the effectiveness of the treatment may vary based on the disease scenario. Interestingly, when transplanted in vivo, MSCs are governed by the locally regulated microenvironment, suggesting that the restorative variability could be tailored by choosing a priming regimen to specifically correct a given pathology. Therefore, in our opinion, the priming of MSCs could be a novel approach to improve the responses of COVID19 patients. Twit Text FOAVip Primed Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients ????Stem Cell Rev Rep http://www.kidney.de/pget.php?&tw=1&pmid=32592163 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32592163 #FOAvip English Wikipedia <ref>{{Cite pmid|32592163}}</ref> Primed Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients #MMPMID32592163 Raza SS; Seth P; Khan MA Stem Cell Rev Rep 2021[Feb]; 17 (1): 153-162 PMID32592163show ga The COVID19 pandemic, designated as a public health crisis by the World Health Organization (WHO), is rapidly spreading around the world impacting the health and economy of almost all the countries. The data of hospitalized COVID19 patients, especially those with serious illness, indicate the involvement of immunopathological complications. As no effective treatment is currently available, we propose 'Primed' Mesenchymal Stem Cells (MSCs) as a therapeutic alternative to tackle devastating epidemic. The individual response to MSCs treatment is heterogeneous. During the treatment of infectious pathology, the effectiveness of the treatment may vary based on the disease scenario. Interestingly, when transplanted in vivo, MSCs are governed by the locally regulated microenvironment, suggesting that the restorative variability could be tailored by choosing a priming regimen to specifically correct a given pathology. Therefore, in our opinion, the priming of MSCs could be a novel approach to improve the responses of COVID19 patients. |*Mesenchymal Stem Cell Transplantation[MESH] |*Pandemics[MESH] |COVID-19/immunology/*therapy/virology[MESH] |Humans[MESH] |Immunomodulation/*immunology[MESH] |Mesenchymal Stem Cells/immunology[MESH] Primed Mesenchymal Stem Cells: a Potential Novel Therapeutic for COV(epmc).pdf DeepDyve Pubget Overpricing